user avatar
Matt Tsai
@thematttsai
Hospitalist MD @BIDMC_IM @harvardmed via @UVMLarnerMed β€’ Christian β€’ Med Educator + Innovative Teaching |πŸ«€πŸ« Crit Pathophys Aficionado | Opinions my own. πŸ€™
Boston, MA
Joined July 2015
Posts
  • Pinned
    user avatar
    How many times have you heard: β€œPatient's MAP is 50! What pressor should we start?” A 🧡on shock and pressors... /1
  • user avatar
    Took some time last week to focus on my own learning gaps regarding DIGOXIN πŸ’Š What are its 2 main indications? How does it work for those indications? How do we monitor toxicity and how do we treat? This is what I've learned, in a tweetorial🧡(graphic at the end!) /1
  • user avatar
    Spent yesterday reviewing some common coagulation 🩸labs and their interpretations. Here is a graphic I made as a refresherπŸ™‚ Keep reading for a few additional points on PT and PTT. /1
  • user avatar
    First time on the wards as a senior resident this week, with @ShreyaTrivediMD as my attending (talk about pressure to impress)! I'm prepping a talk to my interns on Acute Kidney Injury. Here is a tweetorial 🧡 on how I think about AKI. Take-home graphics at the end!πŸ˜€ /1
  • user avatar
    I am fascinated by Right❀️Catheterizations and wish I had learned how to interpret its results earlier than I did in my intern year. Sharing some of the lessons I've been taught in this graphic (thanks to @ShreyaTrivediMD for extensive feedback and support)!
  • user avatar
    Replying to @thematttsai
    Thanks for following along! πŸ™‚ Hope you enjoyed this thread as much as I enjoyed making it. Shoutout to @BIDMC_IM PCCM Dr Ginny Brady for her feedback! /END
  • user avatar
    Replying to @thematttsai
    First let’s review🚨SHOCK: a state of decreased perfusion enough to cause end organ damage (AKI, mental status change, elevated LFTs etc). Not all shock requires a low blood pressure, but thinking about shock in terms of low MAP can be helpful to organize its etiologies πŸ‘‡ /2
  • user avatar
  • user avatar
    Replying to @thematttsai
    Dobutamine and milrinone are ino-dilators: they ⬆️ inotropy while⬇️SVR. This can be useful in structural cardiogenic β™₯️ shock when poor cardiac output is the issue and afterload reduction is key to offloading the heart. See how these compare to other pressors πŸ‘‡ /8
  • user avatar
    Replying to @thematttsai
    Norepinephrine is usuallyπŸ₯‡first-line in vasodilatory shock, e.g. septic shock. It acts primarily on alpha 1 (+ some beta 1) receptors resulting in vasoconstriction with mild inotropy. Great for Low SVR states like sepsis! πŸ‘‡snapshot of @SCCM Surviving Sepsis Guidelines /5
  • user avatar
    Replying to @thematttsai
    Phenylephrine is a pure alpha 1 agonist, offering vasoconstriction without any inotropy. In fact it can often cause reflex bradycardia. Ideal for Afib RVR with hypotension, in situations where cardioversion 🌩️fails or is not feasible. /11
  • user avatar
    Replying to @thematttsai
    Lastly, remember that NOT all shock should be managed with pressors. πŸ₯€Resuscitate Hypovolemia. πŸ› οΈFix Obstruction. πŸ’ŠTreat hypothyroidism or adrenal insufficiency. 🧐Consider mixed etiologies. /14
  • user avatar
    Replying to @thematttsai
    Contrast w/ Vasopressin, a pure vasoconstrictor by V1 receptor agonism and common adjunct to Norepi. VASST trial found no overall mortality difference in septic shock between Norepi + Vaso compared to Norepi alone…but did find benefit among 1 subgroup: less severe sepsis. /6
  • user avatar
    I've been spending this month on the infectious disease service🦠and thinking more deeply about a favorite antibiotic on the wards...vancomycin! Why do we use it and when does it *actually* work? Sharing what I've learned in a🧡 1/n #medtwitter #medstudenttwitter